Protect Pharmaceutical Commences Production of a New Kind of Green: Cannabis-Based “Green Wine”
28 mai 2020 11h58 HE
|
PROTECT PHARMACEUTICAL Corp
Sevnica, Slovenia, May 28, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp is excited to announce the commencement of its production of cannabis-based...
Rafarma Announces Cooperative Research Programs with the Faculty of Medicine, Khon Kaen University, Thailand
10 févr. 2020 11h30 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Feb. 10, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Rafarma is moving forward with its research initiatives for medicinal cannabis in Thailand. The...
Rafarma Adds Thai Corporate Officer to Solidify Market Entry in Thailand Cannabis Industry
09 janv. 2020 14h10 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”. Rafarma Pharmaceuticals, Inc. is pleased to welcome a new Executive Vice-President for Thai...
RAFARMA Welcomes New CEO Vladimir Dolgolenko
12 juil. 2019 07h35 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, July 12, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Mr. Srečo Bojt...
RAFARMA’s Blockchain Tech Ready for Thailand’s Approved Uses of Cannabis
08 juil. 2019 11h51 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, July 08, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (OTC: RAFA), is pleased to announce the commencement of negotiations with the government of the Kingdom of...
Rafarma Joins with Glorija Kotnik to New Victories
30 mai 2019 12h58 HE
|
RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia , May 30, 2019 (GLOBE NEWSWIRE) -- Rafarma (OTC: RAFA), a Wyoming Corporation, has hired internationally acclaimed professional snowboarder Glorija Kotnik as its spokesperson and...
![Rafarma Pharmaceuticals, Inc. logo](/news-release/logo/258442/0/258442.jpg?lastModified=12%2F10%2F2016%2000%3A29%3A48&size=2)
Rafarma (RAFA) Enters $50,000,000 Ceftriaxone Market and Signs Long-Term National and Regional Distribution Contracts
06 juin 2013 09h18 HE
|
Rafarma Pharmaceuticals, Inc.
SANDY, Utah, June 6, 2013 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (the "Company") (Pink Sheets:RAFA) announces commencement of production of the antibiotic Ceftriaxone.
Ceftriaxone treats...